The Addition of Sufentanil Interscalene Block in Shoulder Surgery

Bent Gymoese Jorgensen

Status and phase: Completed; Phase 3

Conditions: Postoperative Pain; Shoulder Surgery

Treatments: Drug: Naropin 0.1% cum sufentanil

Study type: Interventional

Funder types: Other

Identifiers

NCT01025102

gymoese007

Details and patient eligibility

About

The purpose of this study is to compare the effects and side effects of interscale block performed with Naropin 0.1% cum sufentanil or Naropin 0.1% in shoulder surgery.

Full description

The purpose of this study is to compare the duration of postoperative analgesia and supplemental opioid consumption and side effects of interscale block performed with Naropin 0.1% cum sufentanil or Naropin 0.1% in shoulder surgery

Enrollment: 26 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA I-III
• Age 18-80
• Shoulder surgery performed under interscalene block and general anesthesia

Exclusion criteria

• Contraindication of interscalene block
• Severe chronic obstructive lung disease
• Non-cooperative patient
• Intolerance to opioids
• Pregnancy
• Rheumatoid arthritis and diabetes with peripheral polyneuropathy
• Chronic pain or daily opioid intake

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

26 participants in 1 patient group

Naropin 0.1%

Experimental group

Treatment:

Drug: Naropin 0.1% cum sufentanil